Portfolio company
Axiom Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This deep-tech company develops covalent medicines for pharmaceutical organisations using an artificial intelligence drug discovery platform.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
DeepMirror
This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.
DaltonTx
This company provides an adaptive artificial intelligence platform for drug discovery to pharmaceutical, biotechnology and contract research organisations.
Cime Therapeutics
The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.
Aqemia
This company develops a drug discovery platform using physics-based algorithms and artificial intelligence for pharmaceutical and biotechnology organisations.
Deepcure
This company develops small molecule therapies for pharmaceutical organisations to treat inflammatory and autoimmune diseases using artificial intelligence and automated discovery tools.
A-Alpha Bio
This deep-tech company provides protein interaction data and predictive models to pharmaceutical firms for the discovery and engineering of new medicines.
Celeris Therapeutics
The company develops artificial intelligence software to design and discover protein degrader drugs for pharmaceutical and biotechnology organisations.
Aureka Biotechnologies
The company develops artificial intelligence platforms and antibody therapeutics for pharmaceutical and biotechnology organisations to accelerate the discovery and design of medicines.
